Antidepressant Suicide – A Catch-22

What’s wrong with this picture? Company A designs a drug. The company develops it, tests it on animals and ultimately humans, and sends the results of their research—or what they claim are the results—to the Food and Drug Administration (FDA). The FDA approves the drug to be marketed for the treatment [...]

By | July 20th, 2016|Blog, Paxil News, Pharma News, R. Brent Wisner|

Paxil Suicide Case Heads to Trial

No More Stalling of Paxil Suicide Case Chicago, Illinois, January 14, 2016 — A federal judge in Illinois has ruled that a Paxil suicide case alleging GlaxoSmithKline (“GSK”) concealed data linking its antidepressant drug Paxil to suicidal behavior will move forward to trial, bypassing the drug maker’s two motions for summary [...]

By | January 14th, 2016|Blog, Paxil News, Pharma News, Press Releases|

Twenty First Century Snake Oil Salesman

A Modern Tale of Perfidy and Comeuppance (A “Fiction” inspired by an article in the September 17, 2015 issue of The Chronicle of Higher Education) Here’s the deal: A medical doctor who acts as a “key opinion leader” (KOL) for Big Pharma puts his or her name on an article [...]

By | September 18th, 2015|Blog, Paxil News, Pharma News, Rons Rants|

Misleading Paxil Study Exposed in New BMJ Study

Study 329, a Poster Child of tainted scientific research, has finally gotten its comeuppance. Study 329 was published in 2001 by over a dozen well-credentialed academics whose names lent credence to the study’s conclusions, but unbeknownst to the medical community and public, the study was ghostwritten by a PR company hired [...]

By | September 18th, 2015|Michael L. Baum, Paxil News, Pharma News|

Widow Blames Weak Warning Label on Generic Paxil for Husband’s Suicide

Stewart Dolin took six generic Paxil (paroxetine) tablets in the days before he took his own life in 2010. According to a lawsuit filed by his widow, the small number of prescription meds triggered Stewart’s suicide rather than treat his anxiety. "If you ask anyone who knew him, he was [...]

By | May 28th, 2014|Paxil News, Pharma News, Press Releases|

Widow’s Lawsuit Against GSK Alleges Weak Warning Label on Common Antidepressant

NBC 5 News Chicago interviewed antidepressant lawyer, Brent Wisner, about the tragic suicide of prominent Chicago attorney Stewart Dolin. On July 15, 2010, Mr. Dolin took his life after taking the prescribed generic antidepressant drug, Paxil (paroxetine), for six days. Dolin’s wife Wendy, alleges in her lawsuit that the antidepressant triggered [...]

By | May 28th, 2014|Paxil News, Pharma News, R. Brent Wisner|

Federal Judge Rejects GlaxoSmithKline’s Effort to Dismiss Paxil Suicide Case

Reasonable Jury Could Find That the Paxil Label Was Inadequate & Opinions of Plaintiff’s Expert Witnesses Are Reliable On Tuesday, March 30, 2010, Judge David F. Hamilton, sitting by assignment in the United States District Court, Southern District of Indiana, rejected GlaxoSmithKline’s (“GSK”) attempt to dismiss a case involving a [...]

By | March 30th, 2010|Paxil News, Pharma News|

Baum, Hedlund, Aristei & Goldman Achieves Third Preemption Win This Year on Behalf of Their Clients in a Paxil Suicide Case

Jake Garrison Philadelphia, Pennsylvania -- A federal judge in Pennsylvania ruled on Friday, August 29, 2008, that a lawsuit filed by the parents of a 16-year-old New Jersey boy who committed suicide while taking Paxil is not preempted by federal law, as Paxil’s manufacturer, GlaxoSmithKline (GSK), had hoped. [...]

By | September 3rd, 2008|Paxil News, Pharma News|

Federal Judge Reverses Preemption Ruling in Indiana Paxil Suicide Case

Indianapolis, Indiana: A federal judge from Indiana has reversed his prior opinion wherein he dismissed a Paxil suicide case based on federal preemption grounds in re Tucker v. SmithKline Beecham, Corp., dba GlaxoSmithKline Case No. 1:04-cv-1748-DFH-WTL. Attorneys representing the plaintiff had filed a motion asking the court to reconsider its preemption [...]

By | July 19th, 2008|Paxil News, Pharma News|